This talk explores shifting from transactional engagement to ecosystem-based collaboration in pharmaceutical access. It outlines how multisector partnerships, data-sharing, and aligned value propositions can streamline market access, payer negotiations, and patient access pathways. Attendees will learn practical approaches to build collaborative access ecosystems, measure joint value, and navigate governance and risk in a connected healthcare landscape.

• How can pharmaceutical access strategies transition from single transactions to multi-stakeholder ecosystem collaboration to accelerate patient access and payer alignment?
• Which data, metrics, and governance mechanisms are essential to quantify shared value across partners (manufacturers, payers, providers, patients) in access ecosystems?
• What governance models and risk-sharing arrangements best enable sustainable collaboration while maintaining compliance, transparency, and patient safety?
• How should organizations design and pilot ecosystem initiatives to demonstrate tangible improvements in access timelines, affordability, and health outcomes?

• What is the current impact of the MPN policy in the USA?
• How does this relate to price referring or value by perception?
• What are the main risks of this and other possible price control policies?
• How do these changes affect investments in different markets?
• How do this and similar policies affect innovation in the pharmaceutical industry?
• What are the most effective strategic approaches to minimize risk and deal with the challenges?

• Digital Innovation: How to utilize modern digital tools to revolutionize market access?
• Regulatory Innovation: How to navigate evolving EU regulations to maintain pricing competitiveness, uphold health equity, and anticipate data responsibilities ahead of product launch?
• Organizational Innovation: How to design and implement a more flexible, adaptive, and integrated cross-functional collaboration to improve market access strategies in an increasingly globalized and competitive landscape?
• Process Innovation: How to become more agile and show value to internal stakeholders?
• RWE Innovation: How to effectively leverage RWD for better strategy?
• Performance-Based Innovation: How can we create innovative performance-based agreements for sustainable access?
• Strategic Innovation and agility: How to be able to adapt the strategy to specific market challenges?